US$ 27.66
glp-1 receptor agonists and cardiovascular outcome trials an update outcomes in major with Clinical efficacy results from clinical
Description
Phase 3 SYNCHRONIZE trials fully enrolled for obesity (results expected H1 2026)

Deng, F

Oxidative stress is a major contributor to renal injury and is characterized by increased superoxide production, upregulation of NADPH oxidase, and impaired cAMPPKA signaling (Greco et al
GLP-1RAs also reduce intracranial pressure and alleviate headache symptoms associated with conditions like idiopathic intracranial hypertension, particularly in female patients [98101]

All GLP 1 medications with a rodent C-cell tumor signal carry a boxed warning about potential thyroid C-cell tumor risk
